Formoterol, a new long-acting β2-agonist

  • Gary Anderson
Conference paper


Formoterol is a long acting, fast onset of action bronchodilator which is inreasingly widly used for the treatment of reversible airflow obstruction. Extensive clinical trials have demonstrated that formoterol produces bronchodilation lasting 12 hours with a very rapid onset of action (2–3 min.). These properties support the use of formoterol in clinical situations where sustained relief or prophylaxis of airflow obstruction is warranted, for example in moderate or severe asthmatics and those suffering from nocturnal asthma. While the clinical advantages of formoterol over more familiar drugs such as salbutamol and terbutaline have been relatively easy to demonstrate understanding exactly why Formoterol has these properties has required extensive molecular pharmacology and biophysical analysis.


Severe Asthmatic Airflow Obstruction Fast Onset Outer Cell Membrane Nocturnal Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag/Wien 1998

Authors and Affiliations

  • Gary Anderson
    • 1
  1. 1.Ciba-Geigy LimitedBaselSwitzerland

Personalised recommendations